The Filing Desk

Delek US

DK · NYSE · Energy · Financials, fiscal 2016 to 2025

DK · Last close · November 13, 2026
$68.50
Value Delek US yourself

Delek US's revenue fell 9.5% to $10.7 billion in fiscal 2025. Its operating margin was 2.8%, up from −4.2% a year earlier. Free cash flow was $6 million. It paid out $62 million in dividends and buybacks, 984% of free cash flow. The diluted share count fell 5.0%.

DELEK US HOLDINGS, INC. Latest fiscal year ended December 31, 2025 10-K filed February 27, 2026 · 0001628280-26-012664 Updated
Revenue
$10.7B
9.5%
Operating margin
2.8%
7.0 pts
Net income
−$23M
 
Free cash flow
$6M
 
Return on capital
10.4%
24.9 pts
Market cap
$4.3B
Nov 13 close
P/E
3.6x
On $18.87 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Delek US does

Delek US runs oil refineries and a pipeline, storage and distribution business. It calls itself an integrated downstream energy business, meaning it operates after the oil is pumped: it turns crude oil into fuels, and moves, stores and sells crude oil and refined products. It reports two segments, Refining and Logistics.

Refining has four refineries, in Tyler and Big Spring in Texas, El Dorado in Arkansas and Krotz Springs in Louisiana, all in the Gulf Coast region. Together they have a capacity of 302,000 barrels a day, and the company also runs biodiesel facilities. Logistics owns light product terminals, pipelines, storage tanks, water disposal and gas processing capacity, and holds interests in crude oil pipeline joint ventures.

The company earns money from the gap between what it pays for crude oil and what it sells fuels for, and from fees for moving and storing products. It says its operations are heavily regulated, and it competes with many other refiners and logistics companies. It also has to buy or generate renewable fuel credits, known as RINs, to meet federal blending rules.

Its biggest risks, as it describes them

  • A drop in refining margins, which would cut its results and cash flow.
  • Changes in global oil markets that hurt its refineries.
  • Heavy regulation, with the cost of complying with environmental and safety rules.
  • The cost and availability of the renewable fuel credits (RINs) that refiners must obtain.
  • Strong competition in refining and logistics.
From Delek US's annual report on Form 10-K, filed February 27, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2017 to 2023, earnings per share fell 35.1% a year and net income 36.0% a year, while buybacks cut the share count by 10%. Delek US then lost money in fiscal 2024 and 2025.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments856841822736626
Debt incl. finance leases2,2183,0542,6002,7653,270
Net debt (negative means net cash)1,3622,2121,7782,0302,644
Net debt to EBITDA5.9x3.0x3.0x—3.8x
Debt to equity2.2x2.9x2.7x4.8x6.0x
Interest coverage−1.9x19.6x4.0x−1.6x0.9x
Current ratio1.0x1.2x1.0x0.9x0.8x
Quick ratio0.6x0.7x0.6x0.6x0.5x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Delek US's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What Delek US says to expect

  • Enterprise Optimization Plan: annual cash flow improvementsIncreasing the Enterprise Optimization Plan ("EOP") annual run-rate cash flow improvements guidance to at least $250 million
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed November 6, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 14, 2025 and November 13, 2026, no insider bought Delek US shares on the open market, and 14 insiders sold $46.5 million, $38.7 million of it under trading plans set up in advance.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Sep 11, 2026Amber RussellEVP, RefiningSold5,392$75.50$407,096Form 4
Sep 11, 2026William J FinnertyDirectorSold2,943$77.17$227,114Form 4
Sep 4, 2026Vicky SutilDirectorSold plan6,397$71.50$457,386Form 4
Sep 1, 2026Reuven SpiegelEVP, Special ProjectsSold7,500$73.21$549,080Form 4
Aug 24, 2026Gary M Sullivan Jr.DirectorSold27,688$69.01$1.9 millionForm 4
Aug 21, 2026Richard J MarcoglieseDirectorSold2,000$71.05$142,100Form 4
Aug 21, 2026William J FinnertyDirectorSold1,457$64.70$94,268Form 4
Aug 18, 2026Reuven SpiegelEVP, Special ProjectsSold plan10,000$68.21$682,100Form 4
Aug 17, 2026Avigal SoreqPresident & CEO, DirectorSold plan80,000$66.51$5.3 millionForm 4
Aug 17, 2026Mark Wayne HobbsEVP, Delek LogisticsSold plan20,000$64.58$1.3 millionForm 4
Aug 13, 2026Ezra Uzi YeminDirectorSold plan200,000$67.52$13.5 millionForm 4
Jun 29, 2026William J FinnertyDirectorSold plan5,000$51.50$257,500Form 4
The latest 12 of 35 trades. Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score5 of 92 of 95 of 9
Rule of 40−13.1%−32.2%−9.5%
Altman Z''0.57−0.68−0.20
Accruals ratio−12.9%−7.1%−8.3%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassFailFail
Cash from operations is positivePassFailPass
Return on assets roseFailFailPass
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailFail
Current ratio roseFailFailFail
Share count didn't risePassPassPass
Gross margin roseFailFailPass
Revenue rose relative to assetsFailFailFail
F-score5 of 92 of 95 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Delek US side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Delek USFY25−9.5%2.8%0.1%10.4%3.8x5
CalumetFY25−1.2%2.6%1.4%6.2%8.2x5Compare
Suncor EnergyFY25−4.6%——12.5%——Compare
EniFY25−7.5%6.1%5.6%3.3%1.6x—Compare
EquinorFY252.6%23.8%5.6%25.1%0.3x—Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue4,1987,26710,2339,2987,30210,64819,80116,46711,85210,723
Revenue growth−1.7%73.1%40.8%−9.1%−21.5%45.8%86.0%−16.8%−28.0%−9.5%
Gross profit32432973890−261250748548−43612
Research and development——————————
Operating income−49180612492−732−35458245−492301
Net income−154289340311−611−12825720−560−23
Diluted EPS (US$)−2.494.003.954.06−8.31−1.733.590.30−8.77−0.38
Diluted shares (millions)62728777747472656461
Cash flow
Cash from operations248320560575−2833714251,014−67536
Capital expenditure46172322413269222280392428530
Free cash flow202148238162−552149145621−4946
Dividends paid3844808769043606462
Share buybacks6253651782064000
Acquisitions019600006260182181
Stock-based compensation16182126232529283487
Balance sheet at fiscal year end
Cash and short-term investments6899321,079955788856841822736626
Debt incl. finance leases8331,4661,7832,0672,3482,2183,0542,6002,7653,270
Total assets2,9805,9355,7617,0166,1346,8138,1937,1726,6666,848
Total liabilities1,7973,9713,9525,1815,0185,7997,1236,2126,0916,300
Shareholders' equity1,1821,9641,8081,8351,1161,0141,070960575547
Margins and ratios
Gross margin0.8%5.9%9.5%9.6%−3.6%2.4%3.8%3.3%−0.4%5.7%
Operating margin−1.2%2.5%6.0%5.3%−10.0%−0.3%2.3%1.5%−4.2%2.8%
Net margin−3.7%4.0%3.3%3.3%−8.4%−1.2%1.3%0.1%−4.7%−0.2%
Free cash flow margin4.8%2.0%2.3%1.7%−7.6%1.4%0.7%3.8%−4.2%0.1%
Rule of 40 (growth + FCF margin)3.1%75.2%43.1%−7.4%−29.0%47.2%86.7%−13.1%−32.2%−9.5%
Return on capital—9.4%19.3%14.8%−20.6%−1.1%13.3%8.1%−14.5%10.4%
Return on equity—18.4%18.0%17.1%−41.4%−12.0%24.7%1.9%−73.0%−4.1%
Return on assets—6.5%5.8%4.9%−9.3%−2.0%3.4%0.3%−8.1%−0.3%
Net debt to EBITDA2.1x1.6x0.9x1.6x—5.9x3.0x3.0x—3.8x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Delek US's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Delek US.